Endotracheal intubation, a common procedure in newborn care, is associated with pain and car diorespiratory instability. The use of premedication reduces the adverse physiological responses of bradycardia, systemic hypertension, intracranial hy pertension and hypoxia. Perhaps more importantly, premedication decreases the pain and discomfort associated with the procedure. All newborn infants, therefore, should receive analgesic premedication for endotracheal intubation except in emergency situations. Based on current evidence, an optimal protocol for premedication is to administer a vagolytic (intravenous [IV] atropine 20 µg/kg), a rapid-acting analgesic (IV fentanyl 3 µg/kg to 5 µg/ kg; slow infusion) and a short-duration muscle re laxant (IV succinylcholine 2 mg/kg). Intubations should be performed or supervised by trained staff, with close monitoring of the infant throughout.
Endotracheal intubation is a common procedure in newborn care. There is great variation in the frequency of premedication use for intubation, and in the medica tions used [1] [2] . The experience of being intubated is unpleasant [3] and painful [3] [4] , and seriously disturbs the cardiovascular and respiratory status of the new born. Reducing pain is an ethical obligation for those providing care for newborn infants [5] ; although nurses and physicians recognize that tracheal intubation of the newborn is a very painful procedure [4] , they still frequently fail to provide any pain relief [4] .
The use of such agents does not require indisputable proof that they improve the long-term outcomes of the infants; it is possible that they do not do so. There is no absolute proof that awake intubation adversely af fects long-term outcomes in adults undergoing endo tracheal intubation, but that is not used as an excuse for performing this painful and unpleasant act without premedication. The infants under our care are more likely to feel pain [6] and more likely to have adverse long-term outcomes as a result of the serious pain that they experience during intensive care [6] , than an adult in similar circumstances. A humane and ethical ap proach to neonatal intensive care procedures de mands the use of preemptive analgesia before planned painful procedures [7] .
The purpose of the present statement is to review the literature regarding appropriate premedications for in tubation and produce evidence-based recommenda tions for their use.
Methods of statement development
The literature review included a Medline search last updated in June 2010 using PubMed. The following search terms were used: intubation, endotracheal and newborn. The search was limited to human studies in English, French, German or Spanish. The abstracts of the Pediatric Academic Societies were searched for the years 1995 through 2007. A search of Embase was performed for the years 1966 through 2007. The hier archy of evidence from the Centre for Evidence-Based Medicine was applied using levels of evidence for treatment and prognosis (go to http://www.cebm.net and click on the EBM Tools tab, or go directly to www.cebm.net/index.aspx?o=1025).
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In addition, the principal author searched his personal data files, as well as the reference lists of published studies for further potential articles. A published sys tematic review was also examined for references [8] .
The following questions were asked:
• What are the physiological responses to intuba tion?
• What are the effects of premedication on the physi ological responses?
• How can the pain and discomfort of intubation be reduced?
• What are the complications of premedicating an in fant for intubation?
• Under what clinical circumstances is it acceptable to intubate an infant without the use of premedica tion?
• Which premedications have been studied?
• What are the characteristics of an acceptable pro tocol for premedication?
What are the physiological responses to intubation?
The majority of studies have not separated the physio logical responses to intubation from those of laryn goscopy. This is only of importance because laryn goscopy is sometimes performed for other reasons such as checking tube position or examining the upper airway. In such an instance, it should be remembered that laryngoscopy by itself causes adverse physiologi cal changes [9] . Intubation/laryngoscopy causes sys temic and pulmonary hypertension [10] , bradycardia, in tracranial hypertension [11] and hypoxia. The bradycar dia and hypoxia appear to be independent. Hypoxia can be reduced or avoided by the use of preoxygena tion, and by the use of a laryngoscope blade that al lows continuous oxygen insufflation into the pharynx during the procedure. The bradycardia is largely vagal in origin, and it is not prevented by preoxygenation and avoidance of hypoxia [12] . The intracranial pressure in crease appears to be the result of the coughing and struggling of the infant [13] . Systemic arterial hyperten sion has been investigated extensively in hypertensive adults, and appears to be due to an increase in sys temic vascular resistance [14] , probably due to cate cholamine release in response to the intense pain [9] .
Pulmonary hypertension leading to right ventricular failure during intubation has been well described in adults [15] , but pulmonary artery pressures have not been measured in newborn infants during intubation.
What are the effects of premedication on the physiological responses?
The physiological responses to intubation can be re duced or eliminated by the administration of vagolytics, muscle relaxants, analgesics, preoxygenation and gentle technique. Specifically, bradycardia can be largely prevented by the use of atropine [12] ; systemic hypertension can be reduced by adequate analgesia, which also reduces endocrine and endorphin respons es [16] ; and intracranial hypertension can be avoided by the use of muscle relaxants [13] (all evidence level 1b). Intubation is much faster when the infant is paralyzed [13] [17] [18] , whether performed by experienced neonatol ogists [13] , anesthetists [18] or paediatric residents [17] (evidence level 1b), which leads to reduced hypoxia. Fewer attempts are also required [19] [20] .
Two recent studies [19] [20] that gave potent analgesics to all infants, randomly assigned the infants to receive muscle relaxants or no relaxants. Both studies demon strated additional benefits of giving a muscle relaxant.
How can the pain and discomfort of intubation be reduced?
It is ethically imperative to administer analgesia before planned painful interventions unless it can be proven harmful to do so; the reduction of the short-term physi ological sequelae is probably, at least in part, sec ondary to the reduction in pain and discomfort.
Opiates
Morphine appears not to reduce the occurrence of se vere hypoxia with bradycardia during intubation, in comparison with placebo, probably because of the de layed onset of action [21] . It is likely that fentanyl is more effective because of the more rapid onset of ac tion. Other newer agents that are even faster acting may also be more effective. An example of such an agent is remifentanil, which in older subjects, has an onset of action within seconds and a duration of only a few minutes [22] [23] . Limited neonatal pharmacokinetic (PK) and pharmacodynamic (PD) data are available for morphine and fentanyl, but much less are available for remifentanil. A blinded randomized trial [16] showed that meperidine reduced the endocrine responses to intu bation. The very limited PK or PD data that are avail able in the neonate show marked interindividual vari ability of clearance [24] .
Barbiturates
A small randomized trial in term and late preterm in fants [25] showed that thiopental, an anesthetic barbitu rate, reduced apparent pain in newborn infants under going intubation compared with no premedication. However, the very prolonged elimination of thiopental in the neonate raises concern (average elimination half-life 14.9 h) [26] . Methohexital, a barbiturate that is very short acting in older subjects, was associated with smooth intubating conditions and no apparent distress during intubation in an uncontrolled study [27] . Current ly, there appears to be no PK or PD data for the new born.
Propofol
A recent randomized controlled trial [28] compared the use of propofol with morphine, atropine and succinyl choline for intubation of newborn infants. Intubation was faster, oxygen saturations better maintained, and recovery time shorter in the propofol group. Concern has been raised that propofol is a hypnotic agent with out analgesic effect and that the combination of propo fol with an analgesic such as an opioid may be re quired. Limited PK data show extreme variability in clearance, suggesting that methods for individualizing dosage may be required. In older subjects, propofol commonly causes hypotension [29] , and prolonged or repeated use can lead to serious adverse effects; thus, further investigation of single-dose use is required be fore recommending its widespread use.
Midazolam
Nonanalgesic sedatives, by definition, do not reduce pain and, thus, their use alone for intubation is inap propriate. Midazolam appears to be the most common ly used medication in this category [30] . It has not been shown to reduce any physiological changes of intuba tion and has been associated with serious adverse ef fects during intubation [31] . It causes hypotension [31] [32] [33] [34] [35] , decreased cardiac output [32] and decreased cere bral blood flow velocity [31] [34] , has variable kinetics with a half-life that can exceed 22 h [36] [37] and, when used as a prolonged infusion, has been associated with an increase in adverse neurological outcomes [38] . Mida zolam should not be used for intubation purposes in the newborn [29] [39] .
What are the complications of premedicating an infant for intubation?
The risk of complications is one reason frequently giv en for not using premedications [40] . None of the ran domized controlled trials, however, have demonstrated serious complications from premedication given before intubation. A multicentre observational study in France [30] showed no increase in the frequency of complica tions when infants were premedicated. The use of po tent short-acting opiates is occasionally followed by in creased muscle tone including increased tone in the chest wall musculature. This result appears to be rela tively infrequent if the medication is given slowly [41] , and can be treated by administering a muscle relaxant or opioid antagonist.
Infants are now frequently intubated for the purpose of administering surfactant, with a plan to extubate as soon as they have responded adequately. In such a circumstance, one priority for a premedication regimen should be to avoid prolonged adverse respiratory ef fects. Although fentanyl has a prolonged serum halflife in the newborn, averaging 10 h or more, it causes only short-lasting respiratory depression, and infants can be safely extubated less than 1 h after its adminis tration. One potential advantage of ultrashort-acting agents such as remifentanil is a very short serum halflife of only a few minutes and, thus, there is less con cern about potential residual effects. Future premed ication research should examine the effects of the regi men on extubation success.
Under what clinical circumstances is it acceptable to intubate an infant without the use of premedication?
intubation because of an ongoing need for respiratory support, should receive premedication as soon as ap propriate vascular access has been established, which could be by peripheral intravenous (IV) access, central access or the umbilical vein.
Infants with extremely difficult vascular access, in whom multiple IV attempts with consequent discomfort are likely, could be considered for an alternative route of medication administration. Alternatives include via the nasal mucosa (eg, fentanyl is effective by this route) or by inhalation (such as with nitrous oxide [42] or sevoflurane [43] ); rarely, awake intubation can be con sidered. Infants with severely abnormal airways who are likely to be difficult to intubate and need to breath on their own should not receive premedication. Bron choscopic intubation [44] or use of a laryngeal mask air way [45] may be necessary; if the centre does not have experience with these techniques, transfer to an expe rienced centre, using bag and mask ventilation as backup, should be considered.
Which premedications have been studied?
See Table 1 for a summary of the premedications that have been studied. RCT; given to both groups [16] 20 Tern and preterm new borns
No bradycardia

Analgesia/anaesthesia
Fentanyl Potent opiate; PK data available [43] Good analgesic effect Dose requirements for intubation unknown in the newborn, rare oc currence of chest wall rigidity [44] , unpredictable sedative effect [45] Cohort study [40] Used in both arms of numerous small RCTs
Tern and preterm new borns
Showed safety of a protocol including fen tanyl and succinylcholine Alfentanil Potent opiate Dose requirements and kinetics un known RCT; in combination with succinylcholine, vs meperidine without muscle relaxant [20] 20 Tern and preterm new borns Shorter intubation and reduced duration of hypoxia with alfentanil/succinylcholine Morphine Opiate; PK data avail able Sedative effect Dose requirements unknown for this purpose, delayed onset of ac tion limits efficacy for this purpose RCT; morphine vs no premedication [21] 60 Tern and preterm new borns
No effect on severity of physiologic distur bance during intubation RCT; in combination with succinylcholine and atropine [17] vs nothing
Reduced time to intubate, (60 s vs 590 s), fewer attempts and less bradycardia
Meperi dine
Opiate with sedative ef fect Causes nausea in older patients RCT; meperidine vs alfentanil and succinly choline [16] 20 Tern and preterm new borns
More hypoxia than comparison group
Remifen tanil
Potent opiate
Rapid acting, very rapid clearance and short du ration of action, pro vides good levels of anaesthesia
May cause chest wall rigidity, he modynamic effects uncertain in the newborn, limited PK data in the newborn RCT; remifentanil vs morphine [48] Cohort study [49] 20 21
Preterm new borns
to 32 wks' gestation
Improved intubating conditions with remifen tanil
Good intubation conditions, rapid extubation RCT; remifentanil vs fentanyl plus succinyl choline [23] 30 Cohort study [27] 18 Newborns >32 wks' gestation
Good sedation and intubating conditions
Propofol Very rapid acting, pro vides good levels of anaesthesia May cause hypotension, toxicity unknown in the newborn, little data on PK but reduced clearance in the newborn Cohort study [50] 100 Newborns and infants 2.1 kg to 9.2kg under halothane anaesthesia
Short intubation time, excellent intu bating conditions
RCT; propofol vs mor phine, succinylcholine and atropine [28] 63 Term and preterm new borns Shorter intubation and less hypoxia with propofol
Thiopen tal
Rapid-acting anaesthet ic agent
Causes hypotension in older chil dren, prolonged and extremely vari able clearance RCT [25] ; thiopental vs nothing 30 Newborn infants >2kg Blunts hypertensive response
Muscle relaxation
Pancuro nium
Nondepolarizing agent, few side effects Prolonged duration RCT; atropine alone to atropine plus pancuroni um vs nothing [12] 30 Term and preterm newborns Similar increase in intracranial pressure and less hypoxia dur ing intubation
Succinyl choline
Rapid acting, short du ration of action Depolarizing agent, rare serious complications, malignant hyper thermia, hyperkalaemia, rhabdomy olysis 4 RCTs (1 only partly randomized) [13] [16]- [18] 81
Term and preterm newborns
Reduces intracranial pressure increase, shortens duration of the procedure, reduces number of attempts, reduces trauma
Mivacuri um
Nondepolarizing agent, few side effects, brief duration of action Cohort study of use in combination with fen tanyl and atropine [51] 34
Term and preterm newborns
Rapid onset (1-3 min), brief du ration of action (5-15 min), very stable intubation conditions RCT; mivacurium vs no mivacurium (all infants received fentanyl and atropine) [19] 41
Much shorter intubations and less hypoxemia with mivacurium
Rocuroni um
Nondepolarizing agent with rapid onset Prolonged and variable duration (up to 1 h) RCT; rocuronium vs no relaxant (all infants re ceived fentanyl and at ropine [48] 44 Preterm newborns Much more likely to be intubated on first attempt compared with controls CNS Central nervous system; PK Pharmacokinetic; RCT Randomized controlled trial; vs Versus; wks Weeks
What are the characteristics of an acceptable protocol for premedication?
From the above review, it appears that given the cur rent level of knowledge, the optimal protocol is to ad minister a vagolytic, an analgesic and a muscle relax ant. Further research of hypnotic/anesthetic agents such as propofol will be required before recommending their use.
Vagolytic
Glycopyrrolate and atropine are both effective and have not been directly compared. Dose requirements of glycopyrrolate in small preterm infants are not FETUS AND NEWBORN COMMITTEE, CANADIAN PAEDIATRIC SOCIETY | 7
known [46] . Atropine has not been associated with sig nificant adverse effects when given once in the correct dosage. It should be noted that there is no minimum total dose -10 µg/kg to 20 µg/kg is effective and safe.
Analgesia
The optimal analgesic for intubation would have a very rapid onset, no effect on respiratory mechanics, a short duration of action with good sedation, and reli able kinetics. None of the currently available agents fit this profile. Fentanyl, the most widely used analgesic agent, blunts physiological disturbance during intuba tion in adults and older children, and has a good safety profile. No randomized trials of fentanyl as a premed ication for intubation compared with other agents are available. Chest wall rigidity is a rare phenomenon at the doses usually given. It can be reversed with nalox one or the immediate administration of a rapid-acting muscle relaxant, or perhaps prevented by coadminis tration of the relaxant. Fentanyl may reduce respiratory drive; therefore, the team must be ready to maintain an open airway and support the respiration of the infant whenever the drug is given.
According to a number of studies [1][4] , morphine is the most commonly used drug for intubation; however, it does not improve physiological stability during intuba tion when used alone. This may well be because at least 10 min are required for good analgesia after IV administration, suggesting it may not be the optimal drug for analgesia before intubation. The very rapid onset and short duration of action of remifentanil is at tractive; it should be further investigated in the new born. Methohexital and thiopental have only been stud ied in larger preterm and term infants, but warrant fur ther investigation.
Muscle relaxation
The optimal muscle relaxant for intubation would have a rapid onset, short duration of action and few side ef fects. Succinylcholine has been most widely used, but has rare serious side effects and causes an increase in blood pressure after use, simultaneously with the depolarization. Hyperkalemia may occur, but major el evations are uncommon and usually seen in associa tion with significant tissue injury [47] . Succinylcholine may trigger malignant hyperthermia, a rare autosomal dominant disorder of skeletal muscle that remains asymptomatic unless triggering substances are given. Succinylcholine should not be used in infants with hy perkalemia or a family history of malignant hyperther mia.
Of the nondepolarizing agents, mivacurium most closely fits the ideal profile. The duration of action of approximately 8 min to 12 min is reasonable for allow ing tube fixation after intubation, and will allow rapid weaning and extubation if the infant was intubated for a brief procedure such as surfactant administration. However, mivacurium is not currently available in North America and alternative agents (eg, cisatracurium) should be investigated. Rocuronium has been investi gated and has the advantage of a rapid onset of ac tion, but for most purposes, the duration of muscle re laxation (of up to 1 h) is too long and would not be ap propriate.
If the decision is made to intubate using a potent opi ate but without muscle relaxation, we recommend that a muscle relaxant be drawn up in the correct dosage and be available for use in case of chest wall rigidity. For this purpose, succinylcholine, which has the most rapid onset of action, would be appropriate.
Other aspects of endotracheal intubation
Endotracheal intubation is a stressful and potentially dangerous procedure that requires careful monitoring, excellent technique and every effort made to reduce its hazards, in addition to consideration of premedication. Preoxygenation to reduce hypoxia, limiting the duration of attempts to a reasonable maximum duration (such as 30 s), careful observation and monitoring during the procedure (in particular with pulse oximetry), and con firmation of appropriate tube placement with exhaled carbon dioxide detection are required. The procedure should be performed or supervised by individuals with adequate training and experience.
Recommendations
• Intubations should be performed (or supervised) by trained staff with knowledge about the effects of the intubation process and the medications used.
• During intubation, the infant should be monitored closely -pulse oximetry is usually the minimum monitoring required.
• All newborn infants should receive analgesic pre medication for endotracheal intubation, except for emergency intubations during resuscitation or in fants in whom instrumentation of the airway is likely to be extremely difficult (recommendation grade A).
• Vagolytic agents should be strongly considered; at ropine at a dose of 20 µg/kg (there is no absolute minimum dose) is effective and safe if given once. 10 µg/kg may be sufficient. (recommendation grade A).
• Rapid-acting analgesic agents should be given; the current best choice is fentanyl (recommendation grade B).
• Infants should receive fentanyl by slow IV infusion (1 min appears to be adequate) and muscle relax ants should be available when fentanyl is given to a nonintubated infant. Alternatively, routine use of a muscle relaxant following fentanyl administration could be considered.
• Rapid-onset muscle relaxants should be consid ered. Agents of short duration will usually be prefer able; succinylcholine in a dose of 2 mg/kg is cur rently considered to be the best choice (recommen dation grade A).
• A suggested protocol is described in Table 2 .
• Further research is needed to determine the most appropriate medications and sequence. Newer very rapid-acting agents with short durations of action should be further investigated. Long-term outcomes should be assessed. 
